Sameer Al-Maisary
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sameer Al-Maisary has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Matthias Karck
Department of Cardiac Surgery, Heidelberg University Hospital, Heidelberg, Germany
8 shared publicationsGabriele Romano
Department of Cardiac Surgery, Heidelberg University Hospital, Heidelberg, Germany
4 shared publicationsJamila Kremer
Affiliation Department of Cardiac Surgery, Heidelberg University Hospital, Heidelberg, Germany
4 shared publicationsRaffaele De Simone
Affiliation Department of Cardiac Surgery, Heidelberg University Hospital, Heidelberg, Germany
4 shared publications- Gabriele Romano
Department of Cardiac Surgery, Heidelberg University Hospital, Heidelberg, Germany
3 shared publications - Mario Jesús Guzmán-Ruvalcaba
Department of Cardiac Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany
3 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1) , 1020
Age-stratified clinical phenotypes of cardiac implantable electronic device infections: a 20-year retrospective cohort study
Background: The widespread adoption of cardiac implantable electronic devices (CIEDs) has been accompanied by a parallel increase in severe CIED infections. Traditional risk stratification frequently relies on binary age cutoffs, which can obscure how infection phenotypes evolve across a patient’s lifespan. This study evaluated how advancing age—analyzed across ordered chronological strata—correlates with anatomical infection site, device hardware type, microbiology, and in-hospital mortality in patients with CIED infections. Methods: In this retrospective cohort study of 383 patients treated for CIED infections between 2002 and 2022, patients were categorized into five sequential age brackets (< 50 to 80–90 years). Age was modeled both categorically across these strata and continuously to estimate per-decade odds ratios (ORs) for clinical presentation, hardware type, and microbiological findings. Results: The cohort was predominantly male (75.2%) with a mean age of 67.4 years. Pacemaker involvement increased significantly with age ( p < 0.001), whereas implantable cardioverter-defibrillator use declined ( p = 0.036). Localized generator pocket infections demonstrated a pronounced age-dependent gradient, rising from 19.4% in patients under 50 years to 73.0% in octogenarians ( p < 0.001; OR 1.43 per decade, 95% CI: 1.21–1.69). Conversely, systemic presentations—including bacteremia and lead endocarditis—showed no age-dependent trend. In-hospital mortality remained low and stable across age groups ( p = 0.452) but was markedly higher in patients presenting with bacteremia or sepsis compared to those without systemic involvement (16.7% vs. 1.6%, p < 0.001). Conclusions: Analyzing age as a continuous spectrum reveals a distinct clinical phenotype dominated by localized pocket infections and low-power devices, an insight obscured by standard binary age cutoffs. Crucially, mortality risk was driven by systemic bloodstream infection rather than patient age itself, emphasizing that clinical surveillance should prioritize infection phenotype over chronological age alone. Clinical trial number: Not applicable.
- 3 November 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1) , 1020
Open AccessAge-stratified clinical phenotypes of cardiac implantable electronic device infections: a 20-year retrospective cohort study
Background: The widespread adoption of cardiac implantable electronic devices (CIEDs) has been accompanied by a parallel increase in severe CIED infections. Traditional risk stratification frequently relies on binary age cutoffs, which can obscure how infection phenotypes evolve across a patient’s lifespan. This study evaluated how advancing age—analyzed across ordered chronological strata—correlates with anatomical infection site, device hardware type, microbiology, and in-hospital mortality in patients with CIED infections. Methods: In this retrospective cohort study of 383 patients treated for CIED infections between 2002 and 2022, patients were categorized into five sequential age brackets (< 50 to 80–90 years). Age was modeled both categorically across these strata and continuously to estimate per-decade odds ratios (ORs) for clinical presentation, hardware type, and microbiological findings. Results: The cohort was predominantly male (75.2%) with a mean age of 67.4 years. Pacemaker involvement increased significantly with age ( p < 0.001), whereas implantable cardioverter-defibrillator use declined ( p = 0.036). Localized generator pocket infections demonstrated a pronounced age-dependent gradient, rising from 19.4% in patients under 50 years to 73.0% in octogenarians ( p < 0.001; OR 1.43 per decade, 95% CI: 1.21–1.69). Conversely, systemic presentations—including bacteremia and lead endocarditis—showed no age-dependent trend. In-hospital mortality remained low and stable across age groups ( p = 0.452) but was markedly higher in patients presenting with bacteremia or sepsis compared to those without systemic involvement (16.7% vs. 1.6%, p < 0.001). Conclusions: Analyzing age as a continuous spectrum reveals a distinct clinical phenotype dominated by localized pocket infections and low-power devices, an insight obscured by standard binary age cutoffs. Crucially, mortality risk was driven by systemic bloodstream infection rather than patient age itself, emphasizing that clinical surveillance should prioritize infection phenotype over chronological age alone. Clinical trial number: Not applicable.
- Open Access
- 27 October 2026
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 21 (1)
Mapping the global research landscape of ischemia–reperfusion injury in cardiac surgery and transplantation: a bibliometric analysis
Background: Ischemia–reperfusion injury (IRI) is intrinsic to cardiac surgery and heart transplantation, where ischemia is inevitably followed by reperfusion that paradoxically aggravates myocardial damage. Despite decades of research, no universally accepted cardioprotective strategy exists, and the global structure of this literature has not been mapped. We aimed to characterize the scientific landscape of IRI and protective strategies in cardiac surgery and transplantation. Methods: We retrieved documents (articles, reviews and proceedings papers) from the Web of Science Core Collection. No lower date limit was applied; the corpus covers the complete publication years 1979–2025. Performance indicators and science-mapping analyses (co-authorship, keyword co-occurrence, cited-reference analysis, thematic mapping and trend topics) were computed following the Bibliometrix methodology and reported per the BIBLIO guideline. Results: The corpus spanned 1979–2025 across 905 journals and 18,312 authors, accruing 180,256 citations (mean 39.5 per document; h-index 162); 43% of documents appeared in 2015–2025. The United States and China led both production and impact, although roughly 93% of Chinese output postdates 2010; Harvard University, the Chinese Academy of Medical Sciences and Semmelweis University were the most productive institutions. By h-index, the most influential identifiable authors were Heusch, Hausenloy and Yellon. The Annals of Thoracic Surgery and the Journal of Thoracic and Cardiovascular Surgery were the leading journals, and a Bradford core of 23 journals concentrated one third of output. Cited-reference analysis identified the ischemic conditioning lineage as the dominant intellectual base. Ranking protective interventions showed that cardioplegia dominates by volume while the highest citation rates belong to recent, largely preclinical topics; thematic and trend analyses showed a shift from neutrophil- and nitric-oxide–centred inflammation toward mitochondria, regulated cell death and a more recent cluster of mesenchymal stem cells, exosomes, microRNA, melatonin, ferroptosis and donation after circulatory death. Conclusions: Research on IRI in cardiac surgery has matured into a large, internationally collaborative field whose emphasis has been shifting from mechanistic description toward translational and regenerative cardioprotection, although the clinically oriented share of the literature has remained stable since 2010. This map identifies its intellectual foundations, leading contributors and emerging frontiers, offering a structured description that may help orient future cardioprotective research.
- 27 October 2026
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 21 (1)
Open AccessMapping the global research landscape of ischemia–reperfusion injury in cardiac surgery and transplantation: a bibliometric analysis
Background: Ischemia–reperfusion injury (IRI) is intrinsic to cardiac surgery and heart transplantation, where ischemia is inevitably followed by reperfusion that paradoxically aggravates myocardial damage. Despite decades of research, no universally accepted cardioprotective strategy exists, and the global structure of this literature has not been mapped. We aimed to characterize the scientific landscape of IRI and protective strategies in cardiac surgery and transplantation. Methods: We retrieved documents (articles, reviews and proceedings papers) from the Web of Science Core Collection. No lower date limit was applied; the corpus covers the complete publication years 1979–2025. Performance indicators and science-mapping analyses (co-authorship, keyword co-occurrence, cited-reference analysis, thematic mapping and trend topics) were computed following the Bibliometrix methodology and reported per the BIBLIO guideline. Results: The corpus spanned 1979–2025 across 905 journals and 18,312 authors, accruing 180,256 citations (mean 39.5 per document; h-index 162); 43% of documents appeared in 2015–2025. The United States and China led both production and impact, although roughly 93% of Chinese output postdates 2010; Harvard University, the Chinese Academy of Medical Sciences and Semmelweis University were the most productive institutions. By h-index, the most influential identifiable authors were Heusch, Hausenloy and Yellon. The Annals of Thoracic Surgery and the Journal of Thoracic and Cardiovascular Surgery were the leading journals, and a Bradford core of 23 journals concentrated one third of output. Cited-reference analysis identified the ischemic conditioning lineage as the dominant intellectual base. Ranking protective interventions showed that cardioplegia dominates by volume while the highest citation rates belong to recent, largely preclinical topics; thematic and trend analyses showed a shift from neutrophil- and nitric-oxide–centred inflammation toward mitochondria, regulated cell death and a more recent cluster of mesenchymal stem cells, exosomes, microRNA, melatonin, ferroptosis and donation after circulatory death. Conclusions: Research on IRI in cardiac surgery has matured into a large, internationally collaborative field whose emphasis has been shifting from mechanistic description toward translational and regenerative cardioprotection, although the clinically oriented share of the literature has remained stable since 2010. This map identifies its intellectual foundations, leading contributors and emerging frontiers, offering a structured description that may help orient future cardioprotective research.
- Open Access
- 15 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 2996
Clinical Outcomes of Cardiac Implantable Electronic Device Infections in Octogenarians: A 20-Year Retrospective Cohort Study
Background: The global demographic shift towards an aging population has driven a steady, exponential increase in the utilization of cardiac implantable electronic devices (CIEDs). Consequently, device-related infectious complications have emerged as a leading cause of morbidity and healthcare expenditure. Patients in their eighth decade of life—octogenarians (aged 80–90 years)—represent an exceptionally high-risk demographic due to the compounding factors of physiological frailty, immunosenescence, and complex multi-morbidity. Despite this growing demographic, their specific clinical presentations, microbiological profiles, and procedural outcomes following infection remain poorly defined in the current literature. This study aimed to comprehensively compare the clinical characteristics, pathogen distribution, and in-hospital outcomes of CIED infections in an octogenarian cohort against a younger patient population. Methods: We conducted a robust retrospective cohort analysis of 383 consecutive patients treated for confirmed CIED infections at one major tertiary referral center (Heidelberg University Hospital) between January 2002 and December 2022. The cohort was stratified by age into octogenarians (n = 76) and a younger control group (n = 307). We systematically extracted and compared data regarding baseline clinical presentation, chronic comorbidities, detailed microbiological cultures (pocket, blood, and extracted leads), and definitive in-hospital outcomes, primarily mortality and length of stay. Results: The octogenarian cohort exhibited a significantly heavier comorbidity burden, notably higher rates of coronary artery disease (51.3% vs. 29.6%, p < 0.001), systemic hypertension (55.3% vs. 38.1%, p = 0.007), and chronic obstructive pulmonary disease (7.9% vs. 1.6%, p = 0.003). Furthermore, therapeutic systemic anticoagulant use was substantially more prevalent in the elderly group (60.5% vs. 45.0%, p = 0.015). Octogenarians presented overwhelmingly with localized generator pocket infections (73.0% vs. 30.0%, p < 0.001) but paradoxically also demonstrated higher rates of systemic bacteremia and sepsis (26.3% vs. 15.0%, p = 0.019). Microbiological analysis revealed a unique pathogen profile, with Staphylococcus capitis found with significantly higher frequency in the generator pockets of the elderly cohort. Remarkably, despite possessing a higher average lead burden (2.1 vs. 1.2 leads) and extreme comorbidity profiles, octogenarians demonstrated no statistically significant differences in in-hospital mortality (3.9% vs. 4.2%, p = 1.000) or overall length of hospital stay (14.7 vs. 17.2 days, p = 0.386) when compared to the younger cohort. Conclusions: Octogenarians suffering from CIED infections display highly distinct clinical and microbiological profiles, characterized predominantly by elevated rates of localized pocket infections, specific opportunistic pathogens, and a severe underlying comorbidity burden. Crucially, our findings indicate that with the application of modern extraction and management protocols, advanced age alone does not intrinsically correlate with increased in-hospital mortality. Future prevention and perioperative management strategies tailored to this rapidly expanding demographic must heavily prioritize the mitigation of pocket-related complications, particularly considering the high prevalence of concurrent anticoagulation therapy.
- 15 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 2996
Open AccessClinical Outcomes of Cardiac Implantable Electronic Device Infections in Octogenarians: A 20-Year Retrospective Cohort Study
Background: The global demographic shift towards an aging population has driven a steady, exponential increase in the utilization of cardiac implantable electronic devices (CIEDs). Consequently, device-related infectious complications have emerged as a leading cause of morbidity and healthcare expenditure. Patients in their eighth decade of life—octogenarians (aged 80–90 years)—represent an exceptionally high-risk demographic due to the compounding factors of physiological frailty, immunosenescence, and complex multi-morbidity. Despite this growing demographic, their specific clinical presentations, microbiological profiles, and procedural outcomes following infection remain poorly defined in the current literature. This study aimed to comprehensively compare the clinical characteristics, pathogen distribution, and in-hospital outcomes of CIED infections in an octogenarian cohort against a younger patient population. Methods: We conducted a robust retrospective cohort analysis of 383 consecutive patients treated for confirmed CIED infections at one major tertiary referral center (Heidelberg University Hospital) between January 2002 and December 2022. The cohort was stratified by age into octogenarians (n = 76) and a younger control group (n = 307). We systematically extracted and compared data regarding baseline clinical presentation, chronic comorbidities, detailed microbiological cultures (pocket, blood, and extracted leads), and definitive in-hospital outcomes, primarily mortality and length of stay. Results: The octogenarian cohort exhibited a significantly heavier comorbidity burden, notably higher rates of coronary artery disease (51.3% vs. 29.6%, p < 0.001), systemic hypertension (55.3% vs. 38.1%, p = 0.007), and chronic obstructive pulmonary disease (7.9% vs. 1.6%, p = 0.003). Furthermore, therapeutic systemic anticoagulant use was substantially more prevalent in the elderly group (60.5% vs. 45.0%, p = 0.015). Octogenarians presented overwhelmingly with localized generator pocket infections (73.0% vs. 30.0%, p < 0.001) but paradoxically also demonstrated higher rates of systemic bacteremia and sepsis (26.3% vs. 15.0%, p = 0.019). Microbiological analysis revealed a unique pathogen profile, with Staphylococcus capitis found with significantly higher frequency in the generator pockets of the elderly cohort. Remarkably, despite possessing a higher average lead burden (2.1 vs. 1.2 leads) and extreme comorbidity profiles, octogenarians demonstrated no statistically significant differences in in-hospital mortality (3.9% vs. 4.2%, p = 1.000) or overall length of hospital stay (14.7 vs. 17.2 days, p = 0.386) when compared to the younger cohort. Conclusions: Octogenarians suffering from CIED infections display highly distinct clinical and microbiological profiles, characterized predominantly by elevated rates of localized pocket infections, specific opportunistic pathogens, and a severe underlying comorbidity burden. Crucially, our findings indicate that with the application of modern extraction and management protocols, advanced age alone does not intrinsically correlate with increased in-hospital mortality. Future prevention and perioperative management strategies tailored to this rapidly expanding demographic must heavily prioritize the mitigation of pocket-related complications, particularly considering the high prevalence of concurrent anticoagulation therapy.
- Open Access
- 2 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (7) , 2705
Cardiac Implantable Electronic Device Lead Perforation: A 25-Year Single-Center Experience
Background: Cardiac implantable electronic device (CIED) lead perforation is a rare but potentially catastrophic complication. As global device implantations increase, understanding the clinical spectrum and optimal management of this complication is essential. This study characterizes the clinical presentation, diagnostic strategies, and outcomes of lead perforation over a 25-year period. Methods: A retrospective analysis was conducted on 32 patients diagnosed with CIED lead perforation between 2000 and 2025 at a high-volume center. Perforations were classified by timing: acute (30 days). Data included demographics, comorbidities, imaging modalities, and procedural interventions. Results: The mean patient age was 76.0 ± 11.7 years, with a mean body mass index (BMI) of 25.5 ± 3.4 kg/m2. Subacute presentation was the most frequent (59.3%, n = 19), followed by acute (28.1%, n = 9) and chronic (12.5%, n = 4) cases. The right ventricle was the primary site of perforation (90.6%). While chest X-rays served as an initial screening tool in 62.5% of cases, diagnosis relied on multimodal imaging, with Computed Tomography (CT) providing definitive confirmation in 31.3% of the cohort, particularly when lead parameters remained stable. Management was risk-stratified based on hemodynamic status. The majority of patients (71.9%, n = 23) underwent successful transvenous lead removal via simple traction. However, 25% (n = 8) presented with hemodynamic instability, and 21.9% (n = 7) suffered from cardiac tamponade. These high-risk cases required surgical intervention, including sternotomy (n = 4), thoracotomy (n = 2), or pericardiotomy (n = 3). Notably, 62.5% of hemodynamically unstable patients were on oral anticoagulants. All patients survived to discharge, with no in-hospital mortality. The median length of hospital stay was 3 days. Conclusions: CIED lead perforation often presents subacutely with subtle clinical signs. CT imaging has emerged as the gold standard for definitive diagnosis. While percutaneous transvenous removal is safe and effective for stable patients, immediate surgical backup is vital, as patients—particularly those on anticoagulation—can deteriorate rapidly.
- 2 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (7) , 2705
Open AccessCardiac Implantable Electronic Device Lead Perforation: A 25-Year Single-Center Experience
Background: Cardiac implantable electronic device (CIED) lead perforation is a rare but potentially catastrophic complication. As global device implantations increase, understanding the clinical spectrum and optimal management of this complication is essential. This study characterizes the clinical presentation, diagnostic strategies, and outcomes of lead perforation over a 25-year period. Methods: A retrospective analysis was conducted on 32 patients diagnosed with CIED lead perforation between 2000 and 2025 at a high-volume center. Perforations were classified by timing: acute (30 days). Data included demographics, comorbidities, imaging modalities, and procedural interventions. Results: The mean patient age was 76.0 ± 11.7 years, with a mean body mass index (BMI) of 25.5 ± 3.4 kg/m2. Subacute presentation was the most frequent (59.3%, n = 19), followed by acute (28.1%, n = 9) and chronic (12.5%, n = 4) cases. The right ventricle was the primary site of perforation (90.6%). While chest X-rays served as an initial screening tool in 62.5% of cases, diagnosis relied on multimodal imaging, with Computed Tomography (CT) providing definitive confirmation in 31.3% of the cohort, particularly when lead parameters remained stable. Management was risk-stratified based on hemodynamic status. The majority of patients (71.9%, n = 23) underwent successful transvenous lead removal via simple traction. However, 25% (n = 8) presented with hemodynamic instability, and 21.9% (n = 7) suffered from cardiac tamponade. These high-risk cases required surgical intervention, including sternotomy (n = 4), thoracotomy (n = 2), or pericardiotomy (n = 3). Notably, 62.5% of hemodynamically unstable patients were on oral anticoagulants. All patients survived to discharge, with no in-hospital mortality. The median length of hospital stay was 3 days. Conclusions: CIED lead perforation often presents subacutely with subtle clinical signs. CT imaging has emerged as the gold standard for definitive diagnosis. While percutaneous transvenous removal is safe and effective for stable patients, immediate surgical backup is vital, as patients—particularly those on anticoagulation—can deteriorate rapidly.
- Open Access
- 20 October 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (10) , e0284802
Octogenarian patients and laser-assisted lead extraction: Should we put a limit?
Transvenous laser lead extraction (TLE) for cardiac implantable electric devices (CIED) is a challenging procedure especially if performed in octogenarians. In this study we evaluated the safety and efficacy of transvenous laser lead extraction in elderly patients. This is a retrospective study of octogenarian patients who underwent laser-assisted lead extraction (LLE) (GlideLight laser sheath, Philips, San Diego, USA). 270 Consecutive patients were included. Patients were divided into two groups. Octogenarian group and non-octogenarian group. The Data was gathered from patients treated between September 2013 and January 2020 and is retrospectively analyzed. Of 270 consecutive patients, 38 (14.0%) were 80 years old or more. The total number of the extracted leads was 556 among which 84(15.0%) from the Octogenarian group. From these leads were 155 single coil leads, 82 dual coil leads, 129 right ventricular pacing leads, 155 right atrial leads, and 35 left ventricular leads. In the Octogenarian group the number of removed leads was as follows: 13 single coil leads, 10 dual coil leads, 28 right ventricular pacing leads, 28 right atrial leads and 5 left ventricular leads. No mortality was recorded in the Octogenarian group. One patient in the YG suffered from a superior vena cava tear and one patient suffered from pulmonary embolism. In octogenarian laser assisted lead extraction patients is a safe and effective procedure. No increase in morbidity, mortality or perioperative complication could be recorded in this group. Age should not be a limiting factor to perform this procedure.
- 20 October 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (10) , e0284802
Open AccessOctogenarian patients and laser-assisted lead extraction: Should we put a limit?
Transvenous laser lead extraction (TLE) for cardiac implantable electric devices (CIED) is a challenging procedure especially if performed in octogenarians. In this study we evaluated the safety and efficacy of transvenous laser lead extraction in elderly patients. This is a retrospective study of octogenarian patients who underwent laser-assisted lead extraction (LLE) (GlideLight laser sheath, Philips, San Diego, USA). 270 Consecutive patients were included. Patients were divided into two groups. Octogenarian group and non-octogenarian group. The Data was gathered from patients treated between September 2013 and January 2020 and is retrospectively analyzed. Of 270 consecutive patients, 38 (14.0%) were 80 years old or more. The total number of the extracted leads was 556 among which 84(15.0%) from the Octogenarian group. From these leads were 155 single coil leads, 82 dual coil leads, 129 right ventricular pacing leads, 155 right atrial leads, and 35 left ventricular leads. In the Octogenarian group the number of removed leads was as follows: 13 single coil leads, 10 dual coil leads, 28 right ventricular pacing leads, 28 right atrial leads and 5 left ventricular leads. No mortality was recorded in the Octogenarian group. One patient in the YG suffered from a superior vena cava tear and one patient suffered from pulmonary embolism. In octogenarian laser assisted lead extraction patients is a safe and effective procedure. No increase in morbidity, mortality or perioperative complication could be recorded in this group. Age should not be a limiting factor to perform this procedure.
- Open Access
- 1 January 2023
- Published by Sociedade Brasileira de Cirurgia Cardiovascular in Brazilian Journal of Cardiovascular Surgery
- Vol. 38 (5) , e20220361
Symptomatic Upper Extremity Deep Venous Thrombosis After Laser Lead Extraction
Introduction: Laser lead extraction is a well-established method for removing unwanted leads with low morbidity and mortality. In this small series of cases, we documented our experience with venous thrombosis after laser lead extraction.Methods: Retrospective data of patients who underwent laser lead extraction with postoperative axillo-subclavian vein thrombosis between May 2010 and January 2020 were analyzed. Demographic, operative, clinical, and follow-up characteristics of those patients were collected from our medical database.Results: Six patients underwent percutaneous laser lead extraction. Mean age of the patients was 64 & PLUSMN;7 years. And four of them were male. A total of 11 leads with a mean age of 92 & PLUSMN;43.8 months were extracted. Patients presented with painful arm swelling postoperatively.Conclusion: Laser lead extraction may lead to symptomatic upper extremity deep venous occlusion.
- 1 January 2023
- Published by Sociedade Brasileira de Cirurgia Cardiovascular in Brazilian Journal of Cardiovascular Surgery
- Vol. 38 (5) , e20220361
Open AccessSymptomatic Upper Extremity Deep Venous Thrombosis After Laser Lead Extraction
Introduction: Laser lead extraction is a well-established method for removing unwanted leads with low morbidity and mortality. In this small series of cases, we documented our experience with venous thrombosis after laser lead extraction.Methods: Retrospective data of patients who underwent laser lead extraction with postoperative axillo-subclavian vein thrombosis between May 2010 and January 2020 were analyzed. Demographic, operative, clinical, and follow-up characteristics of those patients were collected from our medical database.Results: Six patients underwent percutaneous laser lead extraction. Mean age of the patients was 64 & PLUSMN;7 years. And four of them were male. A total of 11 leads with a mean age of 92 & PLUSMN;43.8 months were extracted. Patients presented with painful arm swelling postoperatively.Conclusion: Laser lead extraction may lead to symptomatic upper extremity deep venous occlusion.
- Open Access
- 30 October 2021
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 16 (1) , 1-6
Risk of venous occlusion after lead laser extraction preventing future lead implantation
Background: Lead laser extraction is a well-established method for removing unwanted leads with low morbidity and mortality. Objective: In this observational study, we documented our experience with venous occlusion after lead laser extraction. Methods: Retrospective data of patients who underwent lead laser extraction between May 2010 and August 2018 was analyzed. Two subgroups of patients were identified. First group represented patients after lead laser extraction who suffered postoperative venous occlusion. Second group represents patients after lead laser extraction, who has documented patent venous access after lead laser extraction. Results: 219 patients underwent percutaneous laser lead extraction. The mean age of patients was 65 ± 14 years. Of these patients, 74% were male. The Most common indication for extraction was Nonfunctional lead (45.2%, n = 99) followed by pocket infection with 33.8% and endocarditis (17.3%). A total number of 447 leads underwent laser extraction. In 7.8% of the patients, lead extraction was partially successful and lead extraction was not successful in only 2.3% of the patients. Only 13 patients developed a documented venous occlusion postoperatively and 26 patients has documented absence of venous occlusion, of whom 17 were under oral anticoagulation. Conclusion: Lead laser extraction may lead to venous occlusion, which is mostly asymptomatic but it prevents future lead implantation. The use of oral anticoagulant may prevent postoperative venous occlusion.
- 30 October 2021
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 16 (1) , 1-6
Open AccessRisk of venous occlusion after lead laser extraction preventing future lead implantation
Background: Lead laser extraction is a well-established method for removing unwanted leads with low morbidity and mortality. Objective: In this observational study, we documented our experience with venous occlusion after lead laser extraction. Methods: Retrospective data of patients who underwent lead laser extraction between May 2010 and August 2018 was analyzed. Two subgroups of patients were identified. First group represented patients after lead laser extraction who suffered postoperative venous occlusion. Second group represents patients after lead laser extraction, who has documented patent venous access after lead laser extraction. Results: 219 patients underwent percutaneous laser lead extraction. The mean age of patients was 65 ± 14 years. Of these patients, 74% were male. The Most common indication for extraction was Nonfunctional lead (45.2%, n = 99) followed by pocket infection with 33.8% and endocarditis (17.3%). A total number of 447 leads underwent laser extraction. In 7.8% of the patients, lead extraction was partially successful and lead extraction was not successful in only 2.3% of the patients. Only 13 patients developed a documented venous occlusion postoperatively and 26 patients has documented absence of venous occlusion, of whom 17 were under oral anticoagulation. Conclusion: Lead laser extraction may lead to venous occlusion, which is mostly asymptomatic but it prevents future lead implantation. The use of oral anticoagulant may prevent postoperative venous occlusion.
- Open Access
- 14 May 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (5) , e0251829
The use of laser lead extraction sheath in the presence of supra-cardiac occlusion of the central veins for cardiac implantable electronic device lead upgrade or revision
The implantation of cardiac implantable electronic devices (CIED) has increased in the last decades with improvement in the quality of life of patients with cardiac rhythm disorders. The presence of bilateral subclavian, innominate or superior vena cava obstruction is a major limitation to device revision and/or upgrade. This is retrospective study of patients who underwent laser-assisted lead extraction (LLE) (GlideLight laser sheath, Spectranetics Corporation, Colorado Springs, USA) with lead revision or upgrade using the laser sheath as a guide rail. Patients with known occlusion, severe stenosis or functional obstruction of the venous access vessels with indwelling leads were included in this study. 106 patients underwent percutaneous LLE with lead revision and/or upgrade. Preoperative known complete occlusion or severe stenosis of access veins was present in 23 patients (21.5%). More patients with implantable cardioverter-defibrillator (ICD) underwent LLE (64.1%) than patients with CRT-Ds (24.5%) and pacemaker patients (11.3%). In total 172 leads were extracted: 79 (45.9%) single-coil defibrillator leads, 35 (20.3%) dual-coil defibrillator leads, 31 (18.0%) right atrial leads, 24 (13.9%) right ventricular leads and three (1.7%) malfunctional coronary sinus left ventricular pacing leads. The mean age of leads was 99.2±65.6 months. The implantation of new leads after crossing the venous stenosis/obstruction was successful in 98 (92.4%) cases. Postoperative complications were pocket hematoma in two cases and wound infection in one case. No peri-operative and no immediate postoperative death was recorded. One intraoperative superior vena cava tear was treated by immediate thoracotomy and surgical repair. In a single-center study on LLE in the presence of supra-cardiac occlusion of the central veins for CIED lead upgrade and revision we could demonstrate a low procedural complication rate with no procedural deaths. Most of the leads could be completely extracted to revise or upgrade the system. Our study showed a low complication rate, with acceptable mortality rates.
- 14 May 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (5) , e0251829
Open AccessThe use of laser lead extraction sheath in the presence of supra-cardiac occlusion of the central veins for cardiac implantable electronic device lead upgrade or revision
The implantation of cardiac implantable electronic devices (CIED) has increased in the last decades with improvement in the quality of life of patients with cardiac rhythm disorders. The presence of bilateral subclavian, innominate or superior vena cava obstruction is a major limitation to device revision and/or upgrade. This is retrospective study of patients who underwent laser-assisted lead extraction (LLE) (GlideLight laser sheath, Spectranetics Corporation, Colorado Springs, USA) with lead revision or upgrade using the laser sheath as a guide rail. Patients with known occlusion, severe stenosis or functional obstruction of the venous access vessels with indwelling leads were included in this study. 106 patients underwent percutaneous LLE with lead revision and/or upgrade. Preoperative known complete occlusion or severe stenosis of access veins was present in 23 patients (21.5%). More patients with implantable cardioverter-defibrillator (ICD) underwent LLE (64.1%) than patients with CRT-Ds (24.5%) and pacemaker patients (11.3%). In total 172 leads were extracted: 79 (45.9%) single-coil defibrillator leads, 35 (20.3%) dual-coil defibrillator leads, 31 (18.0%) right atrial leads, 24 (13.9%) right ventricular leads and three (1.7%) malfunctional coronary sinus left ventricular pacing leads. The mean age of leads was 99.2±65.6 months. The implantation of new leads after crossing the venous stenosis/obstruction was successful in 98 (92.4%) cases. Postoperative complications were pocket hematoma in two cases and wound infection in one case. No peri-operative and no immediate postoperative death was recorded. One intraoperative superior vena cava tear was treated by immediate thoracotomy and surgical repair. In a single-center study on LLE in the presence of supra-cardiac occlusion of the central veins for CIED lead upgrade and revision we could demonstrate a low procedural complication rate with no procedural deaths. Most of the leads could be completely extracted to revise or upgrade the system. Our study showed a low complication rate, with acceptable mortality rates.
- 24 April 2019
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 34 (6) , 424-427
Epicardial pacemaker as a bridge for pacemaker‐dependent patients undergoing explantation of infected cardiac implantable electronic devices
Background and aim of the study Cardiac implantable electronic device (CIED) implantation is associated with an increase in CIED infection. For pacemaker‐dependent patients, temporary pacemaker leads are implanted until infection remission, which allows new CIED implantation. We compared the outcome of pacemaker‐dependent patients with infected CIED based on whether a combined single procedure of epicardial pacemaker implantation with system extraction or a temporary transjugular pacemaker implantation with interval system implantation was performed. Methods This retrospective study included pacemaker‐dependent patients with CIED infection who were divided into two groups: the Tempo and Epi groups. The Tempo group received temporary transvenous pacemaker connected to an external pulse generator. After infection remission, a new permanent pacemaker was implanted, and the temporary pacemaker leads were removed. The Epi group received implantable epicardial right‐ventricular pacemaker through infrasternal inferior pericardiotomy, and a permanent pulse generator was implanted through the same incision between the subcutaneous tissue and abdominal fascia. Results Sixty‐six patients were included. Forty‐two patients with epicardial pacemakers were discharged after 9.5 ± 8.8 days without infection of the newly implanted epicardial pacemaker. Patients with temporary transjugular pacemaker lead were discharged 23 ± 15 days after receiving permanent pacemakers. No serious complications were recorded in the Epi group. Conclusions CIED infections in pacemaker‐dependent patients can be treated through epicardial pacemaker implantation that allows early patient mobility and reduces hospital stay with no risk of epicardial pacemaker infection. Epicardial pacemakers can be used as a bridge until permanent intravenous CIED is implanted or as a replacement for permeant intravenous CIED.
- 24 April 2019
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 34 (6) , 424-427
Epicardial pacemaker as a bridge for pacemaker‐dependent patients undergoing explantation of infected cardiac implantable electronic devices
Background and aim of the study Cardiac implantable electronic device (CIED) implantation is associated with an increase in CIED infection. For pacemaker‐dependent patients, temporary pacemaker leads are implanted until infection remission, which allows new CIED implantation. We compared the outcome of pacemaker‐dependent patients with infected CIED based on whether a combined single procedure of epicardial pacemaker implantation with system extraction or a temporary transjugular pacemaker implantation with interval system implantation was performed. Methods This retrospective study included pacemaker‐dependent patients with CIED infection who were divided into two groups: the Tempo and Epi groups. The Tempo group received temporary transvenous pacemaker connected to an external pulse generator. After infection remission, a new permanent pacemaker was implanted, and the temporary pacemaker leads were removed. The Epi group received implantable epicardial right‐ventricular pacemaker through infrasternal inferior pericardiotomy, and a permanent pulse generator was implanted through the same incision between the subcutaneous tissue and abdominal fascia. Results Sixty‐six patients were included. Forty‐two patients with epicardial pacemakers were discharged after 9.5 ± 8.8 days without infection of the newly implanted epicardial pacemaker. Patients with temporary transjugular pacemaker lead were discharged 23 ± 15 days after receiving permanent pacemakers. No serious complications were recorded in the Epi group. Conclusions CIED infections in pacemaker‐dependent patients can be treated through epicardial pacemaker implantation that allows early patient mobility and reduces hospital stay with no risk of epicardial pacemaker infection. Epicardial pacemakers can be used as a bridge until permanent intravenous CIED is implanted or as a replacement for permeant intravenous CIED.
- 1 March 2017
- Published by Edizioni Minerva Medica in The Journal of Cardiovascular Surgery
- Vol. 58 (3) , 481-488
The geometrical effect of different annuloplasty rings on mitral valve annulus
Article: The geometrical effect of different annuloplasty rings on mitral valve annulus - The Journal of Cardiovascular Surgery 2017 June;58(3):481-8 - Minerva Medica - Journals
- 1 March 2017
- Published by Edizioni Minerva Medica in The Journal of Cardiovascular Surgery
- Vol. 58 (3) , 481-488
The geometrical effect of different annuloplasty rings on mitral valve annulus
Article: The geometrical effect of different annuloplasty rings on mitral valve annulus - The Journal of Cardiovascular Surgery 2017 June;58(3):481-8 - Minerva Medica - Journals